HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A 2-year longitudinal study of myopia progression and optical component changes among Hong Kong schoolchildren.

Abstract
This study investigated refractive error and optical component changes in a group of 142 Hong Kong schoolchildren from age 6 to 17 years over a 2-year period between 1991 and 1993. Subjects were refracted subjectively and corneal curvatures and ocular dimensions were measured. At the end of the 2-year study, the mean spherical equivalent refraction (SER) was -1.86 D (SD 1.99 D) and 62% of the schoolchildren were myopic. The annual incidence of myopia was 11.8%. Children aged 10 years and under had a greater change in SER toward myopia than older children. The annual rate of myopia progression for the myopic children was -0.46 D (SD 0.40 D) and the rate of progression was greatest between age 6 and 10 years old. Vitreous depth/axial length elongation was the main component contributing to the progression of myopia. Hong Kong schoolchildren develop myopia as early as 6 years old and myopia progresses at a greater rate compared with children of European extraction.
AuthorsC S Lam, M Edwards, M Millodot, W S Goh
JournalOptometry and vision science : official publication of the American Academy of Optometry (Optom Vis Sci) Vol. 76 Issue 6 Pg. 370-80 (Jun 1999) ISSN: 1040-5488 [Print] United States
PMID10416931 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Age Factors
  • Child
  • Cornea (physiopathology)
  • Disease Progression
  • Eye (physiopathology)
  • Female
  • Follow-Up Studies
  • Hong Kong (epidemiology)
  • Humans
  • Incidence
  • Male
  • Myopia (epidemiology, pathology, physiopathology)
  • Prevalence
  • Refraction, Ocular
  • Retrospective Studies
  • Sex Factors
  • Vitreous Body (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: